ABSCIENCES (EPA:AB) AB Science will host a live webcast on indolent systemic mastocytosis on November 20, 2019
Retour
Directive transparence : information réglementée
04/11/2019 19:27
Tweeter
02/12/2019 22:31
AB Science provides the summary of webcast with Key Opinion Leaders on...
27/11/2019 08:34
AB Science will host a live webcast on masitinib in severe asthma on...
26/11/2019 19:15
AB Science will host a live webcast on masitinib in severe asthma on...
25/11/2019 08:21
AB Science provides the summary of webcast with Key Opinion Leaders on...
07/11/2019 20:29
AB Science announces positive top-line Phase 3 results for oral masitinib...
06/11/2019 22:21
AB Science announces the first presentation of preclinical results for...
06/11/2019 08:23
AB Science has signed a financing agreement in order to pre-finance the...
04/11/2019 19:27
AB Science will host a live webcast on indolent systemic mastocytosis on...
10/10/2019 08:03
AB Science provides update on masitinib programs timelines
19/08/2019 20:58
AB Science annouces the success of a private placement
Voir tous les communiqués de ABSCIENCES